𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus–related systemic vasculitis

✍ Scribed by Patrice Cacoub; David Saadoun; Nicolas Limal; Damien Sene; Olivier Lidove; Jean-Charles Piette

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
70 KB
Volume
52
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness of hepatitis C treatment w
Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients
✍ Paul Feuerstadt; Ari L. Bunim; Heriberto Garcia; Jordan J. Karlitz; Hatef Massou 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB 👁 1 views

Randomized controlled trials of hepatitis C virus (HCV) therapy with pegylated interferon and ribavirin have demonstrated sustained viral response rates (SVRs) of 54%-63% (efficacy). Treatment results in clinical practice (effectiveness) may not be equivalent. The goal of this study was to assess th

Pegylated interferon alpha-2b plus ribav
Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues
✍ Ming-Lung Yu; Chia-Yen Dai; Jee-Fu Huang; Ming-Yen Hsieh; Wan-Long Chuang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 1 views

accurate representation of the data is given in Table 1. 7. The major conclusion of this paper was that monitoring hepatitis C virus RNA levels and varying the duration of therapy can save resources without sacrificing rates of SVR. The authors used the Blackwelder test to test the noninferiority of

Cost-effectiveness of interferon alfa 2b
Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic hepatitis C
✍ W. Ray Kim; John J. Poterucha 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 2 views

In their paper in the November issue of HEPATOLOGY, Younossi et al. 1 may have overestimated the cost effectiveness of interferon-ribavirin treatment. This mainly stems from their failure to take into account the fact that patients who achieve sustained response are not homogenous with respect to th